ClinicalTrials.gov
ClinicalTrials.gov Menu

Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00255606
Recruitment Status : Completed
First Posted : November 21, 2005
Last Update Posted : June 26, 2013
Sponsor:
Information provided by:
National Cancer Institute (NCI)